Sandra Horning is Director of GILEAD SCIENCES, INC.. Currently has a direct ownership of 3,631 shares of GILD, which is worth approximately $327,479. The most recent transaction as insider was on May 03, 2023, when has been sold 1,887 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.63K
0% 3M change
0% 12M change
Total Value Held $327,479

Sandra Horning Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 03 2023
BUY
Grant, award, or other acquisition
-
1,887 Added 34.2%
3,631 Common Stock
May 03 2022
BUY
Exercise of conversion of derivative security
-
1,112 Added 38.94%
1,744 Common Stock
Jan 28 2021
BUY
Exercise of conversion of derivative security
-
632 Added 50.0%
632 Common Stock

Also insider at

MRNA
Moderna, Inc. Healthcare
OLMA
Olema Pharmaceuticals, Inc. Healthcare
RVMD
Revolution Medicines, Inc. Healthcare
EQRX
EQRx, Inc. Healthcare
SH

Sandra Horning

Director
Cambridge, MA

Track Institutional and Insider Activities on GILD

Follow GILEAD SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD